Literature DB >> 4857904

Antibodies to human albumin in cirrhotic sera.

S Hauptman, T B Tomasi.   

Abstract

In a previous paper we described a monoclonal IgM protein with antibody-like activity towards aggregated and native albumin. The present study was initiated to determine whether sera, other than that from patients with macroglobulinemia, contained similar antibody-like activity. It was demonstrated that approximately 40% of the sera from patients with classical Laennec's cirrhosis contained antibodies which agglutinate sheep red blood cells coated with aggregated albumin. The hemagglutinating activity was present in the void volume on Sephadex G-200 chromatography and was shown to be an immunoglobulin by its removal on passage over an anti-L-chain immunoadsorbent column. The immunoglobulin was isolated from cirrhotic sera by chromatography on an albumin immunoadsorbent column. The acid eluate from the albumin affinity column contained only IgA. After labeling this IgA with (125)I and obtaining the Fabalpha fragment by proteolysis, it was shown that the labeled Fabalpha complexed noncovalently with aggregated albumin. Complex formation between albumin and the cirrhotic IgA and Fabalpha could also be demonstrated utilizing facilitation of hemagglutination of sheep red blood cells coated with aggregated albumin. Appropriate controls consisting of normal and myeloma IgA and myeloma Fabalpha fragments failed to show evidence of complex formation with albumin. We propose that the restriction of the antibody response to the IgA class may result from the formation of antibodies against albumin altered during metabolism in the gastrointestinal tract. A possible role for anti-albumin antibodies in normal albumin catabolism and in the pathogenesis of Laennec's cirhosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4857904      PMCID: PMC301531          DOI: 10.1172/JCI107733

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Serum proteins in anacid gastric mucinous secretions.

Authors:  M I HOROWITZ; F HOLLANDER
Journal:  J Biol Chem       Date:  1961-03       Impact factor: 5.157

2.  Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties.

Authors:  J KRITZMAN; H G KUNKEL; J MCCARTHY; R C MELLORS
Journal:  J Lab Clin Med       Date:  1961-06

3.  SEROLOGIC STUDIES OF PROTEOLYTIC FRAGMENTS OF RABBIT AGGLUTINATING ANTIBODIES.

Authors:  H Fudenberg; W J Mandy; A Nisonoff
Journal:  J Clin Invest       Date:  1962-12       Impact factor: 14.808

Review 4.  Albumin metabolism.

Authors:  M A Rothschild; M Oratz; S S Schreiber
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum.

Authors:  M Mannik; D E Stage
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

7.  Studies of human anti-gamma-globulin factors reacting with pepsin-digested gamma-globulins.

Authors:  T G Lawrence; R C Williams
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

8.  Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgM.

Authors:  T A Waldmann; J S Johnson; N Talal
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

9.  A monoclonal IgM protein with antibody-like activity for human albumin.

Authors:  S Hauptman; T B Tomasi
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

10.  Production of a runting syndrome and selective A deficiency in mice by the administration of anti-heavy chain antisera.

Authors:  R A Murgita; C A Mattioli; T B Tomasi
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Immunologic reactivity and alcoholic liver disease.

Authors:  R K Zetterman; C M Leevy
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease.

Authors:  M A Rodriguez; J D Montano; R C Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

3.  Anti-albumin antibodies in chronic liver diseases: diagnostic significance of these antibodies in patients with conventional or immunosuppressive therapy.

Authors:  R Lenkei; L Buligescu; I Belascu; D Pospai; I Dobre
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

4.  In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease.

Authors:  J R Wands; J L Dienstag; J R Weake; R S Koff
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

5.  Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay.

Authors:  B G Hansson; R H Purcell
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Specificities of albumin receptors and albumin antibodies.

Authors:  S N Thung; M A Gerber
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Chronic lymphocytic leukemia cells lack the 185,000-dalton macromolecular insoluble cold globulin present on normal B lymphocytes.

Authors:  M A Simmonds; G Sobczak; S P Hauptman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Anti-albumin antibodies in sera of patients with liver disease.

Authors:  N Tamura; T Suou; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1982-10

9.  Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins.

Authors:  D E Van Epps; S L Brown
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.

Authors:  R C Gupta; E M Tan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.